| dbo:abbreviation
|
- Expert Opin. Ther. Targets
|
| dbo:abstract
|
- Expert Opinion on Therapeutic Targets, abgekürzt Expert Opin. Ther. Targets, ist eine wissenschaftliche Fachzeitschrift, die vom Taylor & Francis-Verlag veröffentlicht wird. Die Zeitschrift erscheint derzeit mit zwölf Ausgaben im Jahr. Es werden Arbeiten zu neuen molekularen Zielstrukturen veröffentlicht. Der Impact Factor lag im Jahr 2014 bei 5,139. Nach der Statistik des ISI Web of Knowledge wird das Journal mit diesem Impact Factor in der Kategorie Pharmakologie und Pharmazie an 18. Stelle von 254 Zeitschriften geführt. (de)
- Expert Opinion on Therapeutic Targets is a monthly peer-reviewed medical journal publishing review articles and original papers on recently identified novel molecular drug targets across all therapy areas. It was originally established as Emerging Therapeutic Targets in 1997, changing to its current name in 2001. The journal evaluates molecules, signal pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and should not include clinical information on specific drugs The audience consists of scientists, managers and decision makers in the pharmaceutical industry, academic researchers working in the field of molecular medicine and others closely involved in R&D. The journal is published by Informa. The Editor in Chief of the journal is Professor Daniele Santini, University Campus Bio-Medico, Rome, Italy (en)
|
| dbo:academicDiscipline
| |
| dbo:country
| |
| dbo:firstPublicationYear
| |
| dbo:frequencyOfPublication
| |
| dbo:impactFactor
| |
| dbo:impactFactorAsOf
| |
| dbo:issn
| |
| dbo:lccn
| |
| dbo:oclc
| |
| dbo:publisher
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 2607 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:abbreviation
|
- Expert Opin. Ther. Targets (en)
|
| dbp:country
| |
| dbp:discipline
| |
| dbp:eissn
| |
| dbp:formerName
|
- Emerging Therapeutic Targets (en)
|
| dbp:frequency
| |
| dbp:history
| |
| dbp:impact
| |
| dbp:impactYear
| |
| dbp:issn
| |
| dbp:language
| |
| dbp:lccn
| |
| dbp:oclc
| |
| dbp:publisher
| |
| dbp:title
|
- Expert Opinion on Therapeutic Targets (en)
|
| dbp:website
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- Expert Opinion on Therapeutic Targets, abgekürzt Expert Opin. Ther. Targets, ist eine wissenschaftliche Fachzeitschrift, die vom Taylor & Francis-Verlag veröffentlicht wird. Die Zeitschrift erscheint derzeit mit zwölf Ausgaben im Jahr. Es werden Arbeiten zu neuen molekularen Zielstrukturen veröffentlicht. Der Impact Factor lag im Jahr 2014 bei 5,139. Nach der Statistik des ISI Web of Knowledge wird das Journal mit diesem Impact Factor in der Kategorie Pharmakologie und Pharmazie an 18. Stelle von 254 Zeitschriften geführt. (de)
- Expert Opinion on Therapeutic Targets is a monthly peer-reviewed medical journal publishing review articles and original papers on recently identified novel molecular drug targets across all therapy areas. It was originally established as Emerging Therapeutic Targets in 1997, changing to its current name in 2001. The journal evaluates molecules, signal pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and should not include clinical information on specific drugs (en)
|
| rdfs:label
|
- Expert Opinion on Therapeutic Targets (de)
- Expert Opinion on Therapeutic Targets (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Expert Opinion on Therapeutic Targets (en)
|
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
